Lipid management in patients with chronic kidney disease-Reference-Cited by-同舟云学术

Lipid management in patients with chronic kidney disease

Published:2018-10-25 Issue:12 Volume:14 Page:727-749
ISSN:1759-5061
Container-title:Nature Reviews Nephrology
language:en
Short-container-title:Nat Rev Nephrol

Author:

Ferro Charles J.,Mark Patrick B.,Kanbay Mehmet,Sarafidis Pantelis,Heine Gunnar H.,Rossignol Patrick,Massy Ziad A.,Mallamaci Francesca,Valdivielso Jose M.,Malyszko Jolanta,Verhaar Marianne C.,Ekart Robert,Vanholder Raymond,London Gerard,Ortiz Alberto^ORCID,Zoccali Carmine

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://www.nature.com/articles/s41581-018-0072-9.pdf

Reference369 articles.

1. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Working Group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int. Suppl. 3, 263–305 (2013).

2. The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Atherosclerosis 253, 281–344 (2016).

3. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Atherosclerosis 252, 207–274 (2016).

4. Jellinger, P. S. et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidaemia and prevention of cardiovascular disease. Endocr. Practice 23, 1–87 (2017).

5. Stone, N. J. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J. Am. Coll. Cardiol. 63, 2889–2934 (2014).

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of peritoneal dialysis and hemodialysis on mortality in patients with end‐stage renal disease: A systematic review and meta‐analysis;Therapeutic Apheresis and Dialysis;2024-08-26

2. Exploratory Research of PCSK9 Inhibitor on Patency of Autogenous Arteriovenous Fistula After Percutaneous Transluminal Angioplasty with Paclitaxel Releasing Balloon: study protocol for a prospective, randomized, controlled trial;2024-08-17

3. The clinical efficacy of combined ESA and Roxadustat treatment for renal anemia in hemodialysis patients with secondary hyperparathyroidism: A case series;Medicine;2024-08-16

4. Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study;Diabetes, Obesity and Metabolism;2024-07-29

5. Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database;BMC Nephrology;2024-07-22